The U.S. International Trade Commission said it will review a judge’s findings that deemed invalid three Bracco patents for a radioisotope infusion system used in heart-imaging procedures, the agency said in a notice posted on its website.
claimsJubilant Life Sciences’s Ruby imaging agent infringes three patents for strontium-rubidium radioisotope infusion systems.
- Bracco is seeking an order to block imports of
JubilantDraxImage systems made in Canada.
- Patents cover a computer-controlled medical device, plus the method of making it and ways to use it to infuse a patient with radioisotope rubidium-82 during an imaging process.
- Several nuclear medicine technologists ...